InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,052.89
(
-0.35%
)
US TECH 100
17,008.40
(
0.03%
)
Dow Jones
38,364.68
(
-0.36%
)
Brent Oil
86.95
(
-0.71%
)
Bitcoin
64,691.52
(
-2.59%
)
Post# of 251587
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119467
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Rocky3 post# 211199

Wednesday, 07/26/2017 12:36:08 PM

Wednesday, July 26, 2017 12:36:08 PM

Post# of 251587
EGRX receives CRL for Ryanodex in heatstroke:

https://finance.yahoo.com/news/eagle-pharmaceuticals-receives-complete-response-163000438.html

…the FDA has requested that the Company conduct an additional clinical trial for RYANODEX for Exertional Heat Stroke.

The NDA was based on one small study conducted in Saudi Arabia.

The stock is currently halted.

p.s. The FDA is not approving everything, as some people have recently asserted.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up